CoChat

Lipophilicity of analogs of pyridoxal isonicotinoyl hydrazone (PIH) determines the efflux of iron complexes and toxicity in K562 cells

Buss, Joan L., Arduini, Emmanuele, Shephard, Kyle C., Ponka, Prem · 2003 · Biochemical Pharmacology

The DOI matches its Crossref record; 33 of the 36 references it cites were found in a registry or an index.

Abstract

Iron overload secondary to beta-thalassemia and other iron-loading anemias is the most serious obstacle to be overcome in the treatment of these diseases, since there is no physiological mechanism for excretion of the excess iron acquired by chronic blood transfusion. Due to the inconvenience and cost of the current iron chelation therapy, the search for an orally available iron chelator is ongoing. Pyridoxal isonicotinoyl hydrazone (PIH) and many of its analogs are effective at mobilizing iron in vivo and in vitro at doses that are not toxic. PIH analogs were approximately equally effective at binding 59Fe within K562 cells; their efficacy depended upon the kinetics of release of the iron-chelator complex from the cell, which was correlated inversely with the lipophilicity of the chelators. Addition of BSA, which has a well-characterized affinity for lipophilic species, to the extracellular medium enhanced iron-chelator efflux, such that all analogs caused 59Fe release from the cells as quickly as it was chelated; this suggests that BSA acts as an extracellular sink for the iron-chelator complexes, many of which are highly lipophilic. The toxicity of the free chelators varied over two orders of magnitude, and was correlated with the amount of intracellular 59Fe-chelator complexes, implicating the complexes in the mechanism of toxicity of the chelators. Understanding the structural features that determine the efficacy and toxicity of iron chelators in biological systems is of value in the selection of PIH analogs for in vivo examination.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0006-2952(02)01551-4

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 33 references

Cited by

See all 41

Metadata

Authors
Buss, J. L., Arduini, E., Shephard, K. C., & Ponka, P.
Affiliations
Jewish General Hospital (CA)
Corresponding author
Ponka, Prem
Venue
Biochemical Pharmacology
Publisher
Elsevier BV
Published
2003-02
Volume
65
Issue
3
Pages
349-360
ISSN
0006-2952 (ISSN-L)
OpenAlex
W2032136371
Cited by
41
References
36
Citations by year
2024: 2 · 2022: 2 · 2021: 2 · 2020: 1 · 2017: 2 · 2016: 1 · 2015: 1 · 2013: 1 · 2012: 3
FWCI
1.98
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Biochemical Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
  • Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
Keywords
pyridoxal isonicotinoyl hydrazone, iron chelators, lipophilicity, iron efflux, beta-thalassemia, iron overload, K562 cells, BSA, oral iron chelation, structure-activity relationship
MeSH terms
Antineoplastic Agents, Biological Transport, Cell Division, Humans, Iron, Iron Chelating Agents, Isoniazid, Pyridoxal, K562 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lipophilicity of analogs of pyridoxal isonicotinoyl hydrazone (PIH) determines the efflux of iron complexes and toxicity in K562 cells. https://app.cochat.ai/papers/10.1016/s0006-2952(02)01551-4
The paper
Buss, J. L., Arduini, E., Shephard, K. C., & Ponka, P. (2003). Lipophilicity of analogs of pyridoxal isonicotinoyl hydrazone (PIH) determines the efflux of iron complexes and toxicity in K562 cells. Biochemical Pharmacology. https://doi.org/10.1016/s0006-2952(02)01551-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.